Dr. Anna Maria Georgiopoulos, MD

Dr. Georgiopoulos practices at Newton-Wellesley Hospital in Newton, Massachusetts, part of Mass General Brigham.

Dr. Georgiopoulos' NPI, 1275506057, was assigned on February 10, 2006. Dr. Georgiopoulos graduated from Mayo Medical School in 1999. Dr. Georgiopoulos holds Massachusetts license 209709.

Dr. Georgiopoulos' primary practice is Newton-Wellesley Hospital, at 2014 Washington Street, Newton, MA 02462 in Middlesex County. The practice phone is (617) 243-6000.

Dr. Georgiopoulos' primary practice is Newton-Wellesley Hospital in Newton, Massachusetts, part of Mass General Brigham. The medical group on file is Massachusetts General Hospital. Dmand AI also links Dr. Georgiopoulos to 1 more hospital outpatient department and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Georgiopoulos practices, 2 sites in all. Vendor and product names are available with a free account.

Psychiatry is Dr. Georgiopoulos' primary specialty in the NPI Registry, under taxonomy code 2084P0800X. Dr. Georgiopoulos is licensed in Massachusetts.

CMS data shows 42 Medicare services from Dr. Georgiopoulos across 1 procedure code in 2023, all of them office visits, for 12 Medicare patients. Medicare paid $4,538 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 12 Medicare patients who saw Dr. Georgiopoulos in 2024. 75% of them have anxiety, and 75% have mood disorders. Their average risk score is 3.51, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Georgiopoulos' median patient age at 29, with 54% women.

In 2024, Dr. Georgiopoulos wrote 1,156 Medicare Part D claims for 16 patients. 99% of them were for generic drugs. CMS names the drug for 1,073 of them, across 8 drugs with 11 or more claims each, at $1,808 in total drug cost. In 2023, CMS named 137 claims across 7 drugs.

Dr. Georgiopoulos accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Georgiopoulos as offering telehealth.

Dmand AI links 48 papers to Dr. Georgiopoulos, published from 2011 to 2025. 2023 was the busiest year, with 10. The most frequent topics are Cystic Fibrosis, Mental Health and Caregivers. Dr. Georgiopoulos has published most often in Pediatr Pulmonol. Dr. Georgiopoulos' most frequent co-authors are Deborah I. Friedman, MD, Lael M. Yonker, MD and Rachel Linnemann, MD.

Dmand AI links Dr. Georgiopoulos to 2 clinical trials. 1 is still active or recruiting. Conditions studied include Cystic Fibrosis, Anxiety Disorders and Infant, Newborn, Diseases. Massachusetts General Hospital sponsors the most, 2.

CMS Open Payments shows 14 general payments to Dr. Georgiopoulos from 1 drug or device company from 2016 to 2025. Consulting fees make up the largest share, 89% of the total. Vertex Pharmaceuticals Incorporated paid the most, $30,209.

Dr. Georgiopoulos graduated from Mayo Medical School in 1999.